InvenireX is developing real-time, ultra-sensitive Nucleic-acid detection instrumentation powered by the latest AI neural networks, to empower our Scientists to accelerate life-sciences research.
Total raised: $636.55K
Funding Rounds 1
| Date | Series | Amount | Investors |
| 18.03.2024 | - | $636.55K | - |
Mentions in press and media 1
| Date | Title | Description | Source |
| 18.03.2024 | InvenireX Raises £500K in Funding | InvenireX, a Newcastle Upon Tyne, UK-based biotech company advancing PCR laboratory tests, raised £5... | finsmes.co... |